Kocsis J H, Croughan J L, Katz M M, Butler T P, Secunda S, Bowden C L, Davis J M
Department of Psychiatry, New York Hospital-Cornell Medical Center, NY 10021.
Am J Psychiatry. 1990 May;147(5):621-4. doi: 10.1176/ajp.147.5.621.
Hospitalized patients were divided into nonpsychotic severely depressed (N = 53), nonpsychotic moderately depressed (N = 54), and psychotic depressed (N = 25) groups and treated with either imipramine or amitriptyline, up to 250 mg/day, for 4 weeks. Good response occurred in 39% of the 38 severely depressed, 67% of the 49 moderately depressed, and 32% of the 19 psychotic depressed patients who completed treatment. The response of the patients with nonpsychotic severe depression did not differ significantly from the response of those with psychotic depression, and both groups fared worse than the group with nonpsychotic moderate depression.
住院患者被分为非精神病性重度抑郁组(N = 53)、非精神病性中度抑郁组(N = 54)和精神病性抑郁组(N = 25),并接受丙咪嗪或阿米替林治疗,剂量最高达250毫克/天,为期4周。在完成治疗的38例重度抑郁患者中,39%有良好反应;49例中度抑郁患者中,67%有良好反应;19例精神病性抑郁患者中,32%有良好反应。非精神病性重度抑郁患者的反应与精神病性抑郁患者的反应无显著差异,且两组的情况均比非精神病性中度抑郁组更差。